Unknown

Dataset Information

0

Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies.


ABSTRACT: Sulfated galactans (SG) isolated from red alga Gracilaria fisheri have been reported to inhibit the growth of cholangiocarcinoma (CCA) cells, which was similar to the epidermal growth factor receptor (EGFR)-targeted drug, cetuximab. Herein, we studied the anti-cancer potency of SG compared to cetuximab. Biological studies demonstrated SG and cetuximab had similar inhibition mechanisms in CCA cells by down-regulating EGFR/ERK pathway, and the combined treatment induced a greater inhibition effect. The molecular docking study revealed that SG binds to the dimerization domain of EGFR, and this was confirmed by dimerization assay, which showed that SG inhibited ligand-induced EGFR dimer formation. Synchrotron FTIR microspectroscopy was employed to examine alterations in cellular macromolecules after drug treatment. The SR-FTIR-MS elicited similar spectral signatures of SG and cetuximab, pointing towards the bands of RNA/DNA, lipids, and amide I vibrations, which were inconsistent with the changes of signaling proteins in CCA cells after drug treatment. Thus, this study demonstrates the underlined anti-cancer mechanism of SG by interfering with EGFR dimerization. In addition, we reveal that FTIR signature spectra offer a useful tool for screening anti-cancer drugs' effect.

SUBMITTER: Boonsri B 

PROVIDER: S-EPMC8145517 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6292912 | biostudies-literature
| S-EPMC5290320 | biostudies-literature
| S-EPMC7577181 | biostudies-literature
| S-EPMC8271424 | biostudies-literature
| S-EPMC9952973 | biostudies-literature
| S-EPMC6317702 | biostudies-literature
| S-EPMC9261823 | biostudies-literature
| S-EPMC7281474 | biostudies-literature
| S-EPMC9440630 | biostudies-literature
| S-EPMC8773714 | biostudies-literature